Review Article
Tumor Angiogenesis as a Target for Dietary Cancer Prevention
Table 2
Endogenous inhibitors of angiogenesis.
| Angiopoietin-2 (in the absence of VEGF) | | Angiostatin | | Antithrombin III fragment | | Arresten | | Canstatin | | Chondromodulin I | | Connective tissue growth factor (CTGF) | | Decorin | | Endorepellin | | Endostatin | | Fibronectin 20-kDa fragment | | Interferons-α, β, and γ | | Interleukin-4 (IL-4) | | Interleukin-10 (IL-10) | | Interleukin-12 (IL-12) | | Interferon-inducible protein-10 (IP-10) | | Kringle 5 | | Metastatin | | METH-1 | | METH-2 | | 2-Methoxyestradiol | | Osteopontin cleavage product | | PEX | | Pigment epithelium-derived factor (PEDF) | | Plasminogen activator inhibitor (PAI) | | Platelet factor-4 | | Prolactin 16-KDa fragment | | Proliferin-related protein | | Prothrombin kringle 2 | | Maspin | | Restin | | Soluble fms-like tyrosine kinase-1 (S-Flt-1) | | SPARC cleavage product | | Tetrahydrocortisol-S | | Tissue inhibitors of matrix metalloproteinases (TIMPs) | | Thrombospondin-1 and -2 | | Transforming growth factor-β (TGF-β) (activated form) | | Troponin-1 | | Tumstatin | | Vascular endothelial growth inhibitor (VEGI) | | Vasostatin | |
|
|